Linked Life Data

19032525

Source:http://linkedlifedata.com/resource/pubmed/id/19032525

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2008-11-26
pubmed:abstractText
We examined the influence of cinacalcet on vascular calcification by measuring the coronary artery calcification score (CACS) in hemodialysis patients who received cinacalcet. The cinacalcet treatment group consisted of eight hemodialysis patients with secondary hyperparathyroidism who received cinacalcet for 7-14 months. The mean CACS change in the treatment group was -0.094/year, showing a decreasing tendency, while that in the control group showed an increasing tendency of 0.034/year. The mean CACS change showed a tendency for improvement in the treatment group, but no significant difference from that in the control group was observed as the number of cases was small (P = 0.102). The results of this study suggest that cinacalcet is effective in preventing the progress of extraosseous calcification.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1744-9987
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
12 Suppl 1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S34-7
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Change in coronary artery calcification score due to cinacalcet hydrochloride administration.
pubmed:affiliation
Division of Nephrology, Meiyo Clinic Hemodialysis Center, Japan. ytsuruta@meiyokai.or.jp
pubmed:publicationType
Journal Article, Controlled Clinical Trial